Daiichi Sankyo Mulls Legal Action Over Ranbaxy Settlements

Law360, New York (May 23, 2013, 3:57 PM EDT) -- Daiichi Sankyo Co. Ltd. is weighing litigation against certain former shareholders of its majority-owned Ranbaxy Laboratories Ltd., saying Wednesday that it believed the shareholders had covered up critical information over tainted drug investigations leading to a recent $500 million U.S. civil and criminal settlement.

According to the Japanese drugmaker, which bought a majority stake in Ranbaxy in 2008, certain shareholders had “concealed and misrepresented" critical information about investigations by the U.S. Department of Justice and U.S. Food and Drug Administration related to adulterated drugs at two of...
To view the full article, register now.